Works matching IS 10781552 AND DT 2024 AND VI 30

Results: 190

The inpatient oncology pharmacist experience in the era of temporary oncologists.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 8, p. 1465, doi. 10.1177/10781552241287715

By:

Hayes, Sarah M;
Preedit, Justine

Publication type:

Article

Cellular therapy site-preparedness: Inpatient pharmacy implementation at a large academic medical center.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 8, p. 1442, doi. 10.1177/10781552241279025

By:

Martino, Janine G.;
McConnell, Kim;
Greathouse, Lorraine;
Rosario, Brent Del;
Jaskowiak, Jaclyn M.

Publication type:

Article

Pacritinib and concurrent azole antifungal therapy is deliverable in patients with hematologic malignancies.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 8, p. 1437, doi. 10.1177/10781552241275205

By:

Trang, Dina;
Ngo, Dat;
Ali, Haris;
Tinajero, Jose

Publication type:

Article

Pembrolizumab related perforated appendicitis.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 8, p. 1455, doi. 10.1177/10781552241271026

By:

Kiracı, Murat;
Akturk Esen, Selin;
Turkay, Duriye Ozer;
Kos, Fahriye Tugba

Publication type:

Article

Incidence of hand-foot syndrome with protein kinase inhibitors in advanced hepatocellular carcinoma patients who received atezolizumab-bevacizumab combination.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 8, p. 1432, doi. 10.1177/10781552241269738

By:

Perrier, Marine;
Zuccaro, Emma;
Carlier, Claire;
Brugel, Mathias;
Slimano, Florian;
Bouché, Olivier

Publication type:

Article

Successful treatment of PD1-inhibitor induced psoriasiform dermatitis using IL-17 blockade without compromising immunotherapy efficacy.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 8, p. 1450, doi. 10.1177/10781552241269712

By:

Greene, Adina;
Penner, Scott;
Edmond, Amanda;
Camou, Monica;
Niu, Jiaxin;
Abbott, Jordan

Publication type:

Article

Dostarlimab: A promising new PD-1 inhibitor for cancer immunotherapy.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 8, p. 1411, doi. 10.1177/10781552241265058

By:

Farzeen, Zubaria;
Khan, Rana Rashad Mahmood;
Chaudhry, Ayoub Rashid;
Pervaiz, Muhammad;
Saeed, Zohaib;
Rasheed, Shahzad;
Shehzad, Behram;
Adnan, Ahmad;
Summer, Muhammad

Publication type:

Article

Polypharmacy and drug-drug interactions in metastatic breast cancer patients receiving cyclin-dependent kinase (CDK) 4/6 inhibitors.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 8, p. 1403, doi. 10.1177/10781552231218959

By:

Kapagan, Tanju;
Bulut, Nilufer;
Erdem, Gokmen Umut

Publication type:

Article

Safety outcomes of pembrolizumab with platinum agent chemotherapy combined with 5-fluorouracil or taxane derivative in head and neck cancer.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 8, p. 1397, doi. 10.1177/10781552231217686

By:

Lee, Benjamin;
Chehab, Sarah S;
Fan, Wenyi;
Schell, Michael J;
Kirtane, Kedar S;
Shah, Anand B

Publication type:

Article

National survey of safe handling of hazardous drugs in hospital settings: Use of an innovative approach.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 8, p. 1385, doi. 10.1177/10781552231216101

By:

Pinet, Emma;
Langlais, Annie;
Chouinard, Audrey;
Bussières, Jean-François;
Tanguay, Cynthia

Publication type:

Article

Impact of telephone follow-up on hepatocellular carcinoma patients receiving oral chemotherapy from an ambulatory-care setting.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 8, p. 1378, doi. 10.1177/10781552231215427

By:

Sakata, Yukio;
Nomura, Hisanaga;
Nakajima, Hirofumi;
Kitajima, Tomomi;
Ito, Yukiko;
Yamamoto, Yoshiya

Publication type:

Article

Incidence of immune-related adverse events in U.S. veterans treated with immune checkpoint inhibitors.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 8, p. 1372, doi. 10.1177/10781552231214800

By:

Krall, Courtney;
Tague, Marshall;
Lund, Brian C

Publication type:

Article

Relative dose intensity of taxane-based chemotherapy in breast cancer patients in a tertiary hospital.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 8, p. 1364, doi. 10.1177/10781552231214467

By:

Helwani, Amira M;
Al Suleimani, Yousuf M;
Al Baimani, Khalid;
Abdelrahman, Aly M

Publication type:

Article

Rapid drug desensitization to taxanes: a descriptive study from Turkey.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 8, p. 1358, doi. 10.1177/10781552231213318

By:

Yeşilkaya, Selma;
Aksu, Kurtuluş;
Vural Solak, Gürgün Tuğçe;
Demir, Şenay;
Topel, Musa;
Erçelebi, Dilek Çuhadar;
Koca Kalkan, İlkay;
Ateş, Hale;
Köycü Buhari, Gözde;
Nazik Bahçecioğlu, Sakine

Publication type:

Article

Outcomes of weight-based vs. fixed dose of Pembrolizumab among patients with non-small cell lung cancer.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 8, p. 1352, doi. 10.1177/10781552231212926

By:

Chaitesipaseut, Lena;
Shah, Nina;
Truong, Thach-Giao;
Niu, Fang;
Shin, Patrick;
Sharma, Kavita;
Smith, Joshua;
Hui, Rita L

Publication type:

Article

Temporal effect of imatinib adherence on time to remission in chronic myeloid leukemia patients.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 8, p. 1343, doi. 10.1177/10781552231212207

By:

Clark, Samantha E.;
Marcum, Zachary A.;
Radich, Jerry;
Etzioni, Ruth;
Basu, Anirban

Publication type:

Article

Impact of relative dose intensity on pathologic complete response in human epidermal growth factor receptor 2 positive breast cancer patients receiving neoadjuvant TCHP.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 8, p. 1335, doi. 10.1177/10781552231212206

By:

Collette, Kaylyn;
Perkey, Cassandra L.;
Adams, Val;
Shelton, Brent J.;
Corum, Lauren S.;
Butts, Allison

Publication type:

Article

Optimizing antimicrobial prophylaxis strategies in acute leukemia patients: Assessing the efficacy of fluconazole.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 8, p. 1330, doi. 10.1177/10781552231212204

By:

Teran, Nicholas S.;
Park, Grace S.

Publication type:

Article

Patterns of prescription opioid use and opioid-related harms among adult patients with hematologic malignancies.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 8, p. 1317, doi. 10.1177/10781552231210788

By:

Nabulsi, Nadia A;
Sharp, Lisa K;
Sweiss, Karen I;
Patel, Pritesh R;
Calip, Gregory S;
Lee, Todd A

Publication type:

Article

Development of oral oncolytic nonadherence estimator (ORACLE): A pretreatment nonadherence risk assessment for oral oncolytics.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 8, p. 1307, doi. 10.1177/10781552231208442

By:

Signorelli, Jessie;
Tran, Thuy;
Sirek, Marie E;
Díaz-Rohena, Yarelis;
Taraba, Jodi L;
Muluneh, Benyam;
Basu, Nayanika;
Lilly, Jennifer;
Darling, Julianne

Publication type:

Article

Assessment of adherence to routine vaccination schedules in oncology patients.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 8, p. 1302, doi. 10.1177/10781552231208434

By:

Sabatino, David C.;
Campbell, Peter;
Santamala, Jennifer

Publication type:

Article

Interleukin-6 as a biomarker of hypersensitivity reactions in chemotherapeutics and monoclonal antibodies.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 8, p. 1294, doi. 10.1177/10781552231204367

By:

Villarreal-González, Rosalaura V;
González-Díaz, Sandra;
Vidal-Gutiérrez, Oscar;
de la Cruz-de la Cruz, Carlos;
Pérez-Ibave, Diana C;
Garza-Rodríguez, María L

Publication type:

Article

Inclusion body myositis triggerred with long-term imatinib use.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 8, p. 1460, doi. 10.1177/10781552231168563

By:

Deniz, Rabia;
Güzelbey, Tevfik;
Narinoğlu, Sanem;
Şirin Kalem, Gizem;
Ekmen, Şevket Ali;
Gündoğdu Ünverengil, Gökçen;
Karaali, Zeynep

Publication type:

Article

Enhancing access to expensive oncology medications in Pakistan: The critical role of pharmaceutical patient assistance programs in oncology care.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 7, p. 1287, doi. 10.1177/10781552241280664

By:

Masood, Wardah;
Bhutta, Omar Akhlaq;
Rasheed, Muhammad Ahsan;
Siddiqui, Adeel

Publication type:

Article

Oral lichenoid drug eruption due to osimertinib for lung cancer.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 7, p. 1278, doi. 10.1177/10781552241268693

By:

Alchaikh Hassan, Ruba;
Soliman, Abram;
Dasanu, Constantin A.

Publication type:

Article

Cisplatin-induced bone marrow failure in an adult patient with Fanconi anemia.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 7, p. 1274, doi. 10.1177/10781552241268468

By:

Surmeli, Zeki Gokhan;
Ibrahim, Rehab Helmy Mohamed;
Alkhalfan, Nawaf;
Mahmood, Zeyad

Publication type:

Article

A systematic approach to the management of menses prophylaxis and suppression in pre-menopausal hematologic cancer patients.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 7, p. 1259, doi. 10.1177/10781552241266587

By:

Collins, Jennifer;
Duvall, Adam;
Dworkin, Emily;
Castiel, Mercedes

Publication type:

Article

Concomitant use of calcitonin gene-related peptide (CGRP) antagonists with azole antifungals in patients with hematological malignancies.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 7, p. 1255, doi. 10.1177/10781552241265884

By:

Mehta, Purav;
Ngo, Dat;
Tinajero, Jose

Publication type:

Article

Severe neutropenia probably caused by enzalutamide and abiraterone in a prostate cancer patient.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 7, p. 1268, doi. 10.1177/10781552241264530

By:

Somoza-Fernández, Beatriz;
Escudero-Vilaplana, Vicente;
Collado-Borrell, Roberto;
Pérez-Ramírez, Sara;
Villanueva-Bueno, Cristina;
Montero-Antón, María del Pilar;
Herranz-Alonso, Ana;
Sanjurjo-Saez, María

Publication type:

Article

Immune checkpoint blockade effect on immunologic and virologic profile of five cancer patients living with human immunodeficiency virus (HIV) infection.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 7, p. 1249, doi. 10.1177/10781552241264258

By:

Yazji, Azzam;
Brown, Erika Nicole;
De La Torre, Rodrigo;
Umoru, Godsfavour Oghenero

Publication type:

Article

Medical marijuana in the treatment of cancer-associated symptoms.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 7, p. 1240, doi. 10.1177/10781552241262963

By:

Micha, John P;
Rettenmaier, Mark A;
Bohart, Randy D;
Goldstein, Bram H

Publication type:

Article

A current comprehensive role of immune-checkpoint inhibitors in resectable non-small cell lung cancer: A narrative review.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 7, p. 1214, doi. 10.1177/10781552241260864

By:

Efil, Safa Can;
Bilgin, Burak;
Ceylan, Furkan;
Karakaş, Hilal;
Karahan, İrfan;
Özsan, Sema Nur;
Kosku, Hakan;
Yaman, Şebnem;
Bülent Akıncı, Muhammed;
Dede, Didem Şener;
Yalçın, Bülent;
Nahit Şendur, Mehmet Ali

Publication type:

Article

Cold-associated laryngopharyngeal dysesthesia syndrome after oxaliplatin treatment.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 7, p. 1245, doi. 10.1177/10781552241255289

By:

Babacan, Arzu

Publication type:

Article

Utilization of cefepime therapeutic drug monitoring in febrile neutropenia patients with hematologic malignancies.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 7, p. 1207, doi. 10.1177/10781552231213883

By:

Lodl, Emma F;
Alshaer, Mohammad H;
Adams, C. Brooke;
Richards, Ashley;
Peloquin, Charles;
Venugopalan, Veena

Publication type:

Article

Evaluation of a decentralized investigational drug service pharmacist in a cancer clinical trial infusion unit.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 7, p. 1200, doi. 10.1177/10781552231207854

By:

Baroody, Christina;
Sandler, Melissa;
Hong, Christine;
Madanat, Yazan F;
Conley, Stefanie

Publication type:

Article

Out-of-hours admissions in patients treated with immune checkpoint inhibitors and their primary management with steroids.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 7, p. 1193, doi. 10.1177/10781552231207271

By:

Awan, Sidra;
Bharucha, Pooja;
Steventon, Luke;
Simpson, Helen;
AHMAD, Tanya;
Benafif, Sarah;
Shaw, Heather;
Chambers, Pinkie

Publication type:

Article

Olanzapine within steroid-sparing antiemetic regimen to prevent chemotherapy-induced nausea and vomiting in patients with acute leukemia receiving multi-day intensive chemotherapy.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 7, p. 1186, doi. 10.1177/10781552231205824

By:

Hsu, Grace;
Bernhardi, Ciera;
Lawson, Justin;
Duong, Vu H.;
Emadi, Ashkan;
Niyongere, Sandrine;
Duffy, Alison

Publication type:

Article

Longitudinal evaluation of environmental contamination with hazardous drugs by surface wipe sampling.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 7, p. 1181, doi. 10.1177/10781552231205481

By:

Sessink, Paul JM;
Tans, Birgit;
Spriet, Isabel;
Devolder, David

Publication type:

Article

Real world practices of luspatercept at an academic medical center.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 7, p. 1173, doi. 10.1177/10781552231203721

By:

Koons, Madison;
Signorelli, Jessie R.;
Bell, Chris;
Rowen, Brenna

Publication type:

Article

Efficacy and safety of bone management agents administered at 12 weeks vs. 4 weeks in patients with bone metastases: A systematic review.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 7, p. 1160, doi. 10.1177/10781552231203720

By:

Sato, Junya;
Kodaira, Makoto;
Harada, Hiroyuki;
Iguchi, Haruo;
Yoshida, Taichi;
Shibata, Hiroyuki

Publication type:

Article

Evaluating cost savings in cytotoxic leftover management: A prospective study of vial sharing and dose rounding techniques in the Moroccan National Institute of Oncology.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 7, p. 1152, doi. 10.1177/10781552231203403

By:

El Baraka, Soumaya;
Cherif Chefchaouni, Ali;
Bourdaime, Aya;
Ouedraogo, Jean-Marie;
Shytry, Oumaima;
Belahcen, Mohammed-Jaouad;
Rahali, Younes

Publication type:

Article

Therapeutic adherence and assessment of satisfaction patients with multiple myeloma treated with immunomodulatory drugs in a "real-world" study: Experiences of the Polish Myeloma Group.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 7, p. 1144, doi. 10.1177/10781552231203371

By:

Charliński, Grzegorz;
Grząśko, Norbert;
Bołkun, Łukasz;
Sawicki, Waldemar;
Paczkowska, Edyta;
Druzd-Sitek, Agnieszka;
Usnarska-Zubkiewicz, Lidia;
Butrym, Aleksandra;
Wiater, Elżbieta;
Boguradzki, Piotr;
Budziszewska, Bożena;
Wojciechowska, Małgorzata;
Mordak-Domagała, Monika;
Jurczyszyn, Artur

Publication type:

Article

Clinical and economic impact of oncology-trained pharmacist integration in an ambulatory cancer clinic.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 7, p. 1138, doi. 10.1177/10781552231202221

By:

Mull, Ashley;
Hawkins, Courtney;
Punke, Alexandra;
Parkey, Shannon;
Mallon, Courtney

Publication type:

Article

Impact of pegaspargase dose capping on incidence of pegaspargase-related adverse events in adults.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 7, p. 1130, doi. 10.1177/10781552231202217

By:

Tiao, Emily;
Bernhardi, Ciera L;
Trovato, James A;
Lawson, Justin;
Seung, Hyunuk;
Emadi, Ashkan;
Duffy, Alison P

Publication type:

Article

Leukocytoclastic vasculitis associated with capecitabine.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 7, p. 1282, doi. 10.1177/10781552231167812

By:

Arici, Mustafa Ozgur;
Avsar, Esin;
Kilic, Ozlem;
Salim, Derya Kivrak

Publication type:

Article

Cost burden of chemotherapy for Indonesian healthcare insurance and social security/Jaminan Kesehatan Nasional (JKN) patients with non-Hodgkin lymphoma.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 6, p. 1096, doi. 10.1177/10781552241261250

By:

Yulistiani, Yulistiani;
Abdissalam, Erfan;
Rahem, Abdul;
Hamidi, Nur Fauzi;
Utomo, Febriansyah Nur

Publication type:

Article

A case of palmar-plantar erythrodysesthesia in a lung cancer patient receiving atezolizumab maintenance.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 6, p. 1122, doi. 10.1177/10781552241258175

By:

Teymouri, Farzad;
Dasanu, Constantin A.

Publication type:

Article

Pembrolizumab-induced type 1 diabetes.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 6, p. 1118, doi. 10.1177/10781552241255699

By:

Maia, Ariana;
Soares, Daniela M.;
Azevedo, Sofia;
Pereira, Teresa;
Amaral, Cláudia

Publication type:

Article

Imatinib-induced ulcerative colitis.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 6, p. 1111, doi. 10.1177/10781552241255290

By:

Ma, Zengqing;
Zhao, Jianguo;
Li, Susu;
Gao, Fuping;
Zhang, Chuanyang;
Wu, Lianping;
Lin, Yu

Publication type:

Article

Advancements in the use of nanopharmaceuticals for cancer treatment.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 6, p. 1078, doi. 10.1177/10781552241251757

By:

Bennani, Ismail;
Cherif Chefchaouni, Ali;
Hafidi, Youssef;
Moukafih, Badreddine;
El Marrakchi, Soufiane;
Bandadi, Fatima-Zahra;
Rahali, Younes;
El Kartouti, Abdeslam

Publication type:

Article